← Back to news
NewsJOURNAL OF CLINICAL NEUROMUSCULAR DISEASESaturday, March 7, 2026 · March 7, 2026

What Is in the Myopathy Literature?

WHY IT MATTERS

Recent peer-reviewed research on Pompe disease that may be relevant for patients and caregivers.

This update begins with a discussion of treatable lipid storage myopathies associated with the use of sertraline and ranolazine. We then turn to monoclonal gammopathy-associated myopathies including a more recently identified disorder that is also treatment-responsive, monoclonal gammopathy-associat...

Read on PubMed
Read the original at Journal of clinical neuromuscular disease
ResearchPubMedPompe diseaseHumansMuscular Diseases

Related conditions

Pompe disease

Related news

Int J Circumpolar Health · -213 days ago
A population-based legacy study of myasthenia gravis in Iceland: insights from a small Arctic nation
Published in Int J Circumpolar Health. Hjaltason H et al.
Ther Adv Rare Dis · -183 days ago
Could an outcome-based agreement be operationalized using real-world data from the Canadian Neuromuscular Disease Registry? Perspectives from an expert-led assessment in spinal muscular atrophy
Published in Ther Adv Rare Dis. Mitha A et al.
Health Inf Sci Syst · -183 days ago
PhenoRareAI: Phenotype-based intelligent diagnosis for rare neuromuscular disorders of glycogen storage disease and spinal muscular atrophy
Published in Health Inf Sci Syst. Zhai W et al.
J Allergy Clin Immunol Glob · -30 days ago
Emerging trends and research hot spots in inborn error of immunity: A bibliometric perspective
Published in J Allergy Clin Immunol Glob. Alblooshi H et al.